Cardiac hypertrophy: the good, the bad, and the ugly.

PubWeight™: 6.99‹?› | Rank: Top 1%

🔗 View Article (PMID 12524460)

Published in Annu Rev Physiol on January 09, 2003

Authors

N Frey1, E N Olson

Author Affiliations

1: Department of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, Texas 75390-9148, USA. eric.olson@utsouthwestern.edu

Articles citing this

(truncated to the top 100)

A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci U S A (2006) 10.09

FGF23 induces left ventricular hypertrophy. J Clin Invest (2011) 7.22

Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. J Clin Invest (2005) 5.48

Protein kinases C and D mediate agonist-dependent cardiac hypertrophy through nuclear export of histone deacetylase 5. Mol Cell Biol (2004) 4.49

Histone deacetylases 5 and 9 govern responsiveness of the heart to a subset of stress signals and play redundant roles in heart development. Mol Cell Biol (2004) 4.24

T-tubule remodeling during transition from hypertrophy to heart failure. Circ Res (2010) 3.57

Oxidant stress from nitric oxide synthase-3 uncoupling stimulates cardiac pathologic remodeling from chronic pressure load. J Clin Invest (2005) 3.22

The IL-33/ST2 pathway: therapeutic target and novel biomarker. Nat Rev Drug Discov (2008) 2.90

TRPC6 fulfills a calcineurin signaling circuit during pathologic cardiac remodeling. J Clin Invest (2006) 2.74

Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale. Physiol Rev (2010) 2.68

C/EBPβ controls exercise-induced cardiac growth and protects against pathological cardiac remodeling. Cell (2010) 2.68

Return to the fetal gene program protects the stressed heart: a strong hypothesis. Heart Fail Rev (2007) 2.67

The delta isoform of CaM kinase II is required for pathological cardiac hypertrophy and remodeling after pressure overload. Proc Natl Acad Sci U S A (2009) 2.66

Toward transcriptional therapies for the failing heart: chemical screens to modulate genes. J Clin Invest (2005) 2.65

Cardiac fibroblasts are essential for the adaptive response of the murine heart to pressure overload. J Clin Invest (2009) 2.46

miR-23a functions downstream of NFATc3 to regulate cardiac hypertrophy. Proc Natl Acad Sci U S A (2009) 2.33

Maintenance of cardiac energy metabolism by histone deacetylase 3 in mice. J Clin Invest (2008) 2.31

The MEF2D transcription factor mediates stress-dependent cardiac remodeling in mice. J Clin Invest (2008) 2.24

Biowire: a platform for maturation of human pluripotent stem cell-derived cardiomyocytes. Nat Methods (2013) 2.14

Targeted deletion of microRNA-22 promotes stress-induced cardiac dilation and contractile dysfunction. Circulation (2012) 2.14

Cooperative and individualistic functions of the microRNAs in the miR-23a~27a~24-2 cluster and its implication in human diseases. Mol Cancer (2010) 2.14

Cardiomyocyte-secreted acetylcholine is required for maintenance of homeostasis in the heart. FASEB J (2013) 2.12

AMPK alterations in cardiac physiology and pathology: enemy or ally? J Physiol (2006) 2.09

Selective and direct inhibition of TRPC3 channels underlies biological activities of a pyrazole compound. Proc Natl Acad Sci U S A (2009) 2.08

Prevention and reversal of cardiac hypertrophy by soluble epoxide hydrolase inhibitors. Proc Natl Acad Sci U S A (2006) 2.07

Regulation of cardiac stress signaling by protein kinase d1. Mol Cell Biol (2006) 2.01

Matricellular proteins in cardiac adaptation and disease. Physiol Rev (2012) 2.01

Cardiac copper deficiency activates a systemic signaling mechanism that communicates with the copper acquisition and storage organs. Cell Metab (2010) 1.98

A long noncoding RNA protects the heart from pathological hypertrophy. Nature (2014) 1.96

Pivotal role of cardiomyocyte TGF-β signaling in the murine pathological response to sustained pressure overload. J Clin Invest (2011) 1.94

The dietary compound curcumin inhibits p300 histone acetyltransferase activity and prevents heart failure in rats. J Clin Invest (2008) 1.89

Exogenous NAD blocks cardiac hypertrophic response via activation of the SIRT3-LKB1-AMP-activated kinase pathway. J Biol Chem (2009) 1.86

Dual roles of modulatory calcineurin-interacting protein 1 in cardiac hypertrophy. Proc Natl Acad Sci U S A (2003) 1.84

Altered creatine kinase adenosine triphosphate kinetics in failing hypertrophied human myocardium. Circulation (2006) 1.84

Class IA phosphoinositide 3-kinase regulates heart size and physiological cardiac hypertrophy. Mol Cell Biol (2005) 1.78

Protection conferred by myocardial ATP-sensitive K+ channels in pressure overload-induced congestive heart failure revealed in KCNJ11 Kir6.2-null mutant. J Physiol (2006) 1.70

In search of new therapeutic targets and strategies for heart failure: recent advances in basic science. Lancet (2011) 1.69

Angiotensin-II type 1 receptor and NOX2 mediate TCF/LEF and CREB dependent WISP1 induction and cardiomyocyte hypertrophy. J Mol Cell Cardiol (2011) 1.69

Inactivation of focal adhesion kinase in cardiomyocytes promotes eccentric cardiac hypertrophy and fibrosis in mice. J Clin Invest (2005) 1.61

Cardiac hypertrophy and heart failure development through Gq and CaM kinase II signaling. J Cardiovasc Pharmacol (2010) 1.61

Tear me down: role of calpain in the development of cardiac ventricular hypertrophy. Circ Res (2011) 1.61

Muscle-specific loss of apoptosis-inducing factor leads to mitochondrial dysfunction, skeletal muscle atrophy, and dilated cardiomyopathy. Mol Cell Biol (2005) 1.58

AKAP-Lbc mobilizes a cardiac hypertrophy signaling pathway. Mol Cell (2008) 1.57

Sirolimus affects cardiomyocytes to reduce left ventricular mass in heart transplant recipients. Eur Heart J (2008) 1.56

The cell biology of disease: cellular mechanisms of cardiomyopathy. J Cell Biol (2011) 1.54

Early cardiac hypertrophy in mice with impaired calmodulin regulation of cardiac muscle Ca release channel. J Clin Invest (2007) 1.53

Modulation of adverse cardiac remodeling by STARS, a mediator of MEF2 signaling and SRF activity. J Clin Invest (2007) 1.50

A small molecular activator of cardiac hypertrophy uncovered in a chemical screen for modifiers of the calcineurin signaling pathway. Proc Natl Acad Sci U S A (2004) 1.49

Post-translational modifications regulate class IIa histone deacetylase (HDAC) function in health and disease. Mol Cell Proteomics (2015) 1.49

The CRM1 nuclear export receptor controls pathological cardiac gene expression. Mol Cell Biol (2004) 1.46

CIP, a cardiac Isl1-interacting protein, represses cardiomyocyte hypertrophy. Circ Res (2012) 1.46

Creating order from chaos: cellular regulation by kinase anchoring. Annu Rev Pharmacol Toxicol (2012) 1.44

The discovery of placenta growth factor and its biological activity. Exp Mol Med (2012) 1.43

Corticotropin releasing hormone receptor 2 exacerbates chronic cardiac dysfunction. J Exp Med (2017) 1.39

The Human Myotrophin Variant Attenuates MicroRNA-Let-7 Binding Ability but Not Risk of Left Ventricular Hypertrophy in Human Essential Hypertension. PLoS One (2015) 1.39

Differential activation of stress-response signaling in load-induced cardiac hypertrophy and failure. Physiol Genomics (2005) 1.39

Mathematical model of the neonatal mouse ventricular action potential. Am J Physiol Heart Circ Physiol (2008) 1.37

Telomere attrition and Chk2 activation in human heart failure. Proc Natl Acad Sci U S A (2003) 1.37

Ca2+ oscillation frequency decoding in cardiac cell hypertrophy: role of calcineurin/NFAT as Ca2+ signal integrators. Proc Natl Acad Sci U S A (2008) 1.34

Excessive cardiac insulin signaling exacerbates systolic dysfunction induced by pressure overload in rodents. J Clin Invest (2010) 1.34

Myocyte-restricted focal adhesion kinase deletion attenuates pressure overload-induced hypertrophy. Circ Res (2006) 1.34

Muscle ring finger 1 mediates cardiac atrophy in vivo. Am J Physiol Heart Circ Physiol (2009) 1.33

Changes in the chemical and dynamic properties of cardiac troponin T cause discrete cardiomyopathies in transgenic mice. Proc Natl Acad Sci U S A (2005) 1.32

Orai1 and Stim1 regulate normal and hypertrophic growth in cardiomyocytes. J Mol Cell Cardiol (2010) 1.32

Monoamine oxidase A-mediated enhanced catabolism of norepinephrine contributes to adverse remodeling and pump failure in hearts with pressure overload. Circ Res (2009) 1.32

Fatty acids identified in the Burmese python promote beneficial cardiac growth. Science (2011) 1.30

Cardiac hypertrophy involves both myocyte hypertrophy and hyperplasia in anemic zebrafish. PLoS One (2009) 1.27

Cardiovascular effects of leptin. Nat Rev Cardiol (2009) 1.26

Cardiac hypertrophy and sudden death in mice with a genetically clamped renin transgene. Proc Natl Acad Sci U S A (2004) 1.21

Activation of protein synthesis in cardiomyocytes by the hypertrophic agent phenylephrine requires the activation of ERK and involves phosphorylation of tuberous sclerosis complex 2 (TSC2). Biochem J (2005) 1.21

Epigenetic coordination of embryonic heart transcription by dynamically regulated long noncoding RNAs. Proc Natl Acad Sci U S A (2014) 1.17

Altered sarcoplasmic reticulum calcium cycling--targets for heart failure therapy. Nat Rev Cardiol (2012) 1.15

Phospholipase Cε hydrolyzes perinuclear phosphatidylinositol 4-phosphate to regulate cardiac hypertrophy. Cell (2013) 1.14

S100A1 in cardiovascular health and disease: closing the gap between basic science and clinical therapy. J Mol Cell Cardiol (2009) 1.13

Pacing-induced calcineurin activation controls cardiac Ca2+ signalling and gene expression. J Physiol (2003) 1.12

MMP-2/TIMP-2/TIMP-4 versus MMP-9/TIMP-3 in transition from compensatory hypertrophy and angiogenesis to decompensatory heart failure. Arch Physiol Biochem (2010) 1.12

Local IGF-1 isoform protects cardiomyocytes from hypertrophic and oxidative stresses via SirT1 activity. Aging (Albany NY) (2009) 1.09

Convergence of protein kinase C and JAK-STAT signaling on transcription factor GATA-4. Mol Cell Biol (2005) 1.09

Cardiac anti-remodelling effect of aerobic training is associated with a reduction in the calcineurin/NFAT signalling pathway in heart failure mice. J Physiol (2009) 1.08

Placental growth factor regulates cardiac adaptation and hypertrophy through a paracrine mechanism. Circ Res (2011) 1.08

Resistin promotes cardiac hypertrophy via the AMP-activated protein kinase/mammalian target of rapamycin (AMPK/mTOR) and c-Jun N-terminal kinase/insulin receptor substrate 1 (JNK/IRS1) pathways. J Biol Chem (2011) 1.05

Beneficial effects of soluble epoxide hydrolase inhibitors in myocardial infarction model: Insight gained using metabolomic approaches. J Mol Cell Cardiol (2009) 1.05

Mitochondrial fusion and fission proteins: novel therapeutic targets for combating cardiovascular disease. Br J Pharmacol (2014) 1.04

Comparison of matrix metalloproteinase 9 and brain natriuretic peptide as clinical biomarkers in chronic heart failure. Am Heart J (2008) 1.03

Earliest changes in the left ventricular transcriptome postmyocardial infarction. Mamm Genome (2006) 1.03

Multiple influences of blood flow on cardiomyocyte hypertrophy in the embryonic zebrafish heart. Dev Biol (2011) 1.03

Increased susceptibility to isoproterenol-induced cardiac hypertrophy and impaired weight gain in mice lacking the histidine-rich calcium-binding protein. Mol Cell Biol (2006) 1.02

Roles of TRP channels in the development of cardiac hypertrophy. Naunyn Schmiedebergs Arch Pharmacol (2008) 1.02

The contribution of cellular mechanotransduction to cardiomyocyte form and function. Biomech Model Mechanobiol (2012) 1.02

Spatiotemporally distinct protein kinase D activation in adult cardiomyocytes in response to phenylephrine and endothelin. J Biol Chem (2011) 1.02

'Integrative Physiology 2.0': integration of systems biology into physiology and its application to cardiovascular homeostasis. J Physiol (2011) 1.01

Pathogenesis of Chagas disease: time to move on. Front Biosci (Elite Ed) (2012) 1.01

Pressure overload induces early morphological changes in the heart. Am J Pathol (2012) 1.01

PPAR-gamma in the Cardiovascular System. PPAR Res (2008) 1.01

Potential impact of carbohydrate and fat intake on pathological left ventricular hypertrophy. Cardiovasc Res (2006) 1.00

DYRK1A is a novel negative regulator of cardiomyocyte hypertrophy. J Biol Chem (2009) 1.00

Role for interleukin-1 beta in Trypanosoma cruzi-induced cardiomyocyte hypertrophy. Infect Immun (2003) 1.00

Toll-like receptor 2 regulates interleukin-1beta-dependent cardiomyocyte hypertrophy triggered by Trypanosoma cruzi. Infect Immun (2005) 0.99

A novel miniaturized multimodal bioreactor for continuous in situ assessment of bioartificial cardiac tissue during stimulation and maturation. Tissue Eng Part C Methods (2011) 0.99

Phosphodiesterase 5 inhibition blocks pressure overload-induced cardiac hypertrophy independent of the calcineurin pathway. Cardiovasc Res (2008) 0.99

Articles by these authors

(truncated to the top 100)

A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell (1998) 13.56

Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation. Nature (2000) 8.59

Activation of cardiac gene expression by myocardin, a transcriptional cofactor for serum response factor. Cell (2001) 8.09

Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins. Annu Rev Cell Dev Biol (1998) 7.31

Muscle deficiency and neonatal death in mice with a targeted mutation in the myogenin gene. Nature (1993) 6.75

Requirement of the transcription factor GATA4 for heart tube formation and ventral morphogenesis. Genes Dev (1997) 6.52

Cooperative activation of muscle gene expression by MEF2 and myogenic bHLH proteins. Cell (1995) 6.24

p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells. Science (1995) 6.01

A gene with homology to the myc similarity region of MyoD1 is expressed during myogenesis and is sufficient to activate the muscle differentiation program. Genes Dev (1989) 5.91

Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C. Science (1997) 5.54

A calcineurin-dependent transcriptional pathway controls skeletal muscle fiber type. Genes Dev (1998) 5.14

Regulation of skeletal myogenesis by association of the MEF2 transcription factor with class II histone deacetylases. Mol Cell (2000) 5.13

A new myocyte-specific enhancer-binding factor that recognizes a conserved element associated with multiple muscle-specific genes. Mol Cell Biol (1989) 4.72

Activation of the myocyte enhancer factor-2 transcription factor by calcium/calmodulin-dependent protein kinase-stimulated binding of 14-3-3 to histone deacetylase 5. Proc Natl Acad Sci U S A (2000) 4.27

Signal-dependent activation of the MEF2 transcription factor by dissociation from histone deacetylases. Proc Natl Acad Sci U S A (2000) 4.08

Regulation of cardiac mesodermal and neural crest development by the bHLH transcription factor, dHAND. Nat Genet (1997) 3.89

Analysis of the tendon cell fate using Scleraxis, a specific marker for tendons and ligaments. Development (2001) 3.79

CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo. J Clin Invest (2000) 3.70

Requirement of MADS domain transcription factor D-MEF2 for muscle formation in Drosophila. Science (1995) 3.64

MEF2 responds to multiple calcium-regulated signals in the control of skeletal muscle fiber type. EMBO J (2000) 3.59

IGF-1 induces skeletal myocyte hypertrophy through calcineurin in association with GATA-2 and NF-ATc1. Nature (1999) 3.54

Mef2 gene expression marks the cardiac and skeletal muscle lineages during mouse embryogenesis. Development (1994) 3.53

A genetic blueprint for cardiac development. Nature (2000) 3.45

Combinatorial control of muscle development by basic helix-loop-helix and MADS-box transcription factors. Proc Natl Acad Sci U S A (1996) 3.24

Identification of upstream and intragenic regulatory elements that confer cell-type-restricted and differentiation-specific expression on the muscle creatine kinase gene. Mol Cell Biol (1988) 3.24

Stimulation of slow skeletal muscle fiber gene expression by calcineurin in vivo. J Biol Chem (2000) 3.19

Myogenin resides in the nucleus and acquires high affinity for a conserved enhancer element on heterodimerization. Genes Dev (1990) 3.18

Control of muscle development by dueling HATs and HDACs. Curr Opin Genet Dev (2001) 3.17

PDZ proteins bind, cluster, and synaptically colocalize with Eph receptors and their ephrin ligands. Neuron (1998) 3.09

Acylation of proteins with myristic acid occurs cotranslationally. Science (1987) 3.08

Independent signals control expression of the calcineurin inhibitory proteins MCIP1 and MCIP2 in striated muscles. Circ Res (2000) 3.04

Regulation of the MEF2 family of transcription factors by p38. Mol Cell Biol (1999) 3.02

SM22 alpha, a marker of adult smooth muscle, is expressed in multiple myogenic lineages during embryogenesis. Circ Res (1996) 2.96

Regulation of myogenic differentiation by type beta transforming growth factor. J Cell Biol (1986) 2.90

Expression of the SM22alpha promoter in transgenic mice provides evidence for distinct transcriptional regulatory programs in vascular and visceral smooth muscle cells. J Cell Biol (1996) 2.88

Defining the regulatory networks for muscle development. Curr Opin Genet Dev (1996) 2.79

HEB, a helix-loop-helix protein related to E2A and ITF2 that can modulate the DNA-binding ability of myogenic regulatory factors. Mol Cell Biol (1992) 2.72

Dilated cardiomyopathy and sudden death resulting from constitutive activation of protein kinase a. Circ Res (2001) 2.67

Analysis of the myogenin promoter reveals an indirect pathway for positive autoregulation mediated by the muscle-specific enhancer factor MEF-2. Mol Cell Biol (1992) 2.64

Myocyte-enriched calcineurin-interacting protein, MCIP1, inhibits cardiac hypertrophy in vivo. Proc Natl Acad Sci U S A (2001) 2.64

Specificity of fatty acid acylation of cellular proteins. J Biol Chem (1985) 2.63

Requirement of the MADS-box transcription factor MEF2C for vascular development. Development (1998) 2.63

Myocyte enhancer factor (MEF) 2C: a tissue-restricted member of the MEF-2 family of transcription factors. Proc Natl Acad Sci U S A (1993) 2.53

Association of COOH-terminal-binding protein (CtBP) and MEF2-interacting transcription repressor (MITR) contributes to transcriptional repression of the MEF2 transcription factor. J Biol Chem (2001) 2.45

Mutational analysis of the DNA binding, dimerization, and transcriptional activation domains of MEF2C. Mol Cell Biol (1996) 2.40

Myogenin induces the myocyte-specific enhancer binding factor MEF-2 independently of other muscle-specific gene products. Mol Cell Biol (1991) 2.40

Prevention of cardiac hypertrophy in mice by calcineurin inhibition. Science (1998) 2.39

A subclass of bHLH proteins required for cardiac morphogenesis. Science (1995) 2.39

Activation of MEF2 by muscle activity is mediated through a calcineurin-dependent pathway. EMBO J (2001) 2.38

Smooth muscle myosin heavy chain exclusively marks the smooth muscle lineage during mouse embryogenesis. Circ Res (1994) 2.37

Separable regulatory elements governing myogenin transcription in mouse embryogenesis. Science (1993) 2.36

Calsarcins, a novel family of sarcomeric calcineurin-binding proteins. Proc Natl Acad Sci U S A (2000) 2.33

Identification of a signal-responsive nuclear export sequence in class II histone deacetylases. Mol Cell Biol (2001) 2.32

Transcriptional activity of MEF2 during mouse embryogenesis monitored with a MEF2-dependent transgene. Development (1999) 2.30

A Mef2 gene that generates a muscle-specific isoform via alternative mRNA splicing. Mol Cell Biol (1994) 2.30

FGF inactivates myogenic helix-loop-helix proteins through phosphorylation of a conserved protein kinase C site in their DNA-binding domains. Cell (1992) 2.28

HRT1, HRT2, and HRT3: a new subclass of bHLH transcription factors marking specific cardiac, somitic, and pharyngeal arch segments. Dev Biol (1999) 2.27

D-MEF2: a MADS box transcription factor expressed in differentiating mesoderm and muscle cell lineages during Drosophila embryogenesis. Proc Natl Acad Sci U S A (1994) 2.26

Control of early cardiac-specific transcription of Nkx2-5 by a GATA-dependent enhancer. Development (1999) 2.24

Evidence for serum response factor-mediated regulatory networks governing SM22alpha transcription in smooth, skeletal, and cardiac muscle cells. Dev Biol (1997) 2.23

Decoding calcium signals involved in cardiac growth and function. Nat Med (2000) 2.23

Dermo-1: a novel twist-related bHLH protein expressed in the developing dermis. Dev Biol (1995) 2.19

Activated MEK5 induces serial assembly of sarcomeres and eccentric cardiac hypertrophy. EMBO J (2001) 2.19

Wingless signaling induces nautilus expression in the ventral mesoderm of the Drosophila embryo. Dev Biol (1996) 2.13

Helix-loop-helix proteins as regulators of muscle-specific transcription. J Biol Chem (1993) 2.10

Expression of mef2 genes in the mouse central nervous system suggests a role in neuronal maturation. J Neurosci (1995) 2.10

Mutagenesis of the myogenin basic region identifies an ancient protein motif critical for activation of myogenesis. Proc Natl Acad Sci U S A (1991) 2.08

Serum and fibroblast growth factor inhibit myogenic differentiation through a mechanism dependent on protein synthesis and independent of cell proliferation. J Biol Chem (1986) 2.08

The paired-like homeo box gene MHox is required for early events of skeletogenesis in multiple lineages. Genes Dev (1995) 2.07

Members of the HRT family of basic helix-loop-helix proteins act as transcriptional repressors downstream of Notch signaling. Proc Natl Acad Sci U S A (2000) 2.05

PICK1: a perinuclear binding protein and substrate for protein kinase C isolated by the yeast two-hybrid system. J Cell Biol (1995) 2.05

Scleraxis: a basic helix-loop-helix protein that prefigures skeletal formation during mouse embryogenesis. Development (1995) 1.99

A series of mutations in the D-MEF2 transcription factor reveal multiple functions in larval and adult myogenesis in Drosophila. Dev Biol (1995) 1.98

Heart and extra-embryonic mesodermal defects in mouse embryos lacking the bHLH transcription factor Hand1. Nat Genet (1998) 1.98

The oncogenic forms of N-ras or H-ras prevent skeletal myoblast differentiation. Mol Cell Biol (1987) 1.95

Fos and Jun repress transcriptional activation by myogenin and MyoD: the amino terminus of Jun can mediate repression. Genes Dev (1992) 1.92

Building the heart piece by piece: modularity of cis-elements regulating Nkx2-5 transcription. Development (1999) 1.88

Inactivation of the myogenic bHLH gene MRF4 results in up-regulation of myogenin and rib anomalies. Genes Dev (1995) 1.85

Identification of a prx1 limb enhancer. Genesis (2000) 1.83

Antisocial, an intracellular adaptor protein, is required for myoblast fusion in Drosophila. Dev Cell (2001) 1.83

Multiple roles for the MyoD basic region in transmission of transcriptional activation signals and interaction with MEF2. Mol Cell Biol (1998) 1.82

Inefficient homooligomerization contributes to the dependence of myogenin on E2A products for efficient DNA binding. Mol Cell Biol (1991) 1.79

Specific interaction of the PDZ domain protein PICK1 with the COOH terminus of protein kinase C-alpha. J Biol Chem (1997) 1.78

The transcriptional corepressor MITR is a signal-responsive inhibitor of myogenesis. Proc Natl Acad Sci U S A (2001) 1.76

The bHLH transcription factor dHAND controls Sonic hedgehog expression and establishment of the zone of polarizing activity during limb development. Development (2000) 1.76

Myogenin is required for late but not early aspects of myogenesis during mouse development. J Cell Biol (1995) 1.74

A signaling cascade involving endothelin-1, dHAND and msx1 regulates development of neural-crest-derived branchial arch mesenchyme. Development (1998) 1.71

Capsulin: a novel bHLH transcription factor expressed in epicardial progenitors and mesenchyme of visceral organs. Mech Dev (1998) 1.71

Regulation of creatine phosphokinase expression during differentiation of BC3H1 cells. J Biol Chem (1983) 1.70

FOG-2, a heart- and brain-enriched cofactor for GATA transcription factors. Mol Cell Biol (1999) 1.69

The Mef2c gene is a direct transcriptional target of myogenic bHLH and MEF2 proteins during skeletal muscle development. Development (2001) 1.69

Expression of the novel basic helix-loop-helix gene eHAND in neural crest derivatives and extraembryonic membranes during mouse development. Dev Biol (1995) 1.68

EVEC, a novel epidermal growth factor-like repeat-containing protein upregulated in embryonic and diseased adult vasculature. Circ Res (1999) 1.66

Fatty acylation of cellular proteins. Temporal and subcellular differences between palmitate and myristate acylation. J Biol Chem (1986) 1.65

A GATA-dependent right ventricular enhancer controls dHAND transcription in the developing heart. Development (2000) 1.63

Activated notch inhibits myogenic activity of the MADS-Box transcription factor myocyte enhancer factor 2C. Mol Cell Biol (1999) 1.61

Cyclosporine attenuates pressure-overload hypertrophy in mice while enhancing susceptibility to decompensation and heart failure. Circ Res (1999) 1.58

MHox: a mesodermally restricted homeodomain protein that binds an essential site in the muscle creatine kinase enhancer. Development (1992) 1.58

The myogenic regulatory gene Mef2 is a direct target for transcriptional activation by Twist during Drosophila myogenesis. Genes Dev (1998) 1.56

The combinatorial activities of Nkx2.5 and dHAND are essential for cardiac ventricle formation. Dev Biol (2001) 1.56